{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:37:09Z","timestamp":1791844629832,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1053\/j.gastro.2020.02.032","type":"journal-article","created":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T02:30:58Z","timestamp":1582597858000},"page":"2104-2111.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":122,"title":["Pretreatment Frailty Is Independently Associated With Increased Risk of Infections After Immunosuppression in Patients With Inflammatory Bowel Diseases"],"prefix":"10.1053","volume":"158","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8862-1236","authenticated-orcid":false,"given":"Bharati","family":"Kochar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Winston","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Cagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9436-1821","authenticated-orcid":false,"given":"Ashwin N.","family":"Ananthakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2020.02.032_bib1","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1053\/j.gastro.2018.12.009","article-title":"AGA clinical practice guidelines on the management of mild-to-moderate ulcerative colitis","volume":"156","author":"Ko","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2020.02.032_bib2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/ajg.2018.27","article-title":"ACG clinical guideline: management of Crohn\u2019s disease in adults","volume":"113","author":"Lichtenstein","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2020.02.032_bib3","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.gtc.2009.07.005","article-title":"Safety profile of IBD therapeutics: infectious risks","volume":"38","author":"Afif","year":"2009","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1053\/j.gastro.2020.02.032_bib4","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1136\/gut.2008.163642","article-title":"Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study","volume":"58","author":"Fidder","year":"2009","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2020.02.032_bib5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.crohns.2012.02.015","article-title":"Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases","volume":"7","author":"Ananthakrishnan","year":"2013","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2020.02.032_bib6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2147\/CEG.S206970","article-title":"Patient and physician preferences for ulcerative colitis treatments in the United States","volume":"12","author":"Boeri","year":"2019","journal-title":"Clin Exp Gastroenterol"},{"key":"10.1053\/j.gastro.2020.02.032_bib7","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1111\/apt.13195","article-title":"Diabetes and the risk of infections with immunomodulator therapy in inflammatory bowel diseases","volume":"41","author":"Ananthakrishnan","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2020.02.032_bib8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/ecco-jcc\/jjy143","article-title":"Risk factors associated with Clostridium difficile infection in inflammatory bowel disease: a systematic review and meta-analysis","volume":"13","author":"Balram","year":"2019","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2020.02.032_bib9","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1080\/00365521.2017.1286381","article-title":"Genetic risk factors for serious infections in inflammatory bowel diseases","volume":"52","author":"Sasidharan","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2020.02.032_bib10","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1038\/ajg.2014.313","article-title":"Oral corticosteroids and the risk of serious infections in patients with elderly-onset inflammatory bowel diseases","volume":"109","author":"Brassard","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2020.02.032_bib11","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1053\/j.gastro.2018.04.012","article-title":"Risk of serious and opportunistic infections associated with treatment of inflammatory bowel diseases","volume":"155","author":"Kirchgesner","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2020.02.032_bib12","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1053\/j.gastro.2008.01.012","article-title":"Risk factors for opportunistic infections in patients with inflammatory bowel disease","volume":"134","author":"Toruner","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2020.02.032_bib13","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00535-012-0686-9","article-title":"A\u00a0prospective analysis of the incidence of and risk factors for opportunistic infections in patients with inflammatory bowel disease","volume":"48","author":"Naganuma","year":"2013","journal-title":"J\u00a0Gastroenterol"},{"key":"10.1053\/j.gastro.2020.02.032_bib14","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cgh.2010.09.026","article-title":"Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease","volume":"9","author":"Cottone","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2020.02.032_bib15","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.cgh.2016.10.039","article-title":"Incidence and prevalence of Crohn\u2019s disease and ulcerative colitis in Olmsted County, Minnesota from 1970 through 2010","volume":"15","author":"Shivashankar","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2020.02.032_bib16","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1097\/MIB.0000000000001099","article-title":"Management of inflammatory bowel disease in the elderly patient: challenges and opportunities","volume":"23","author":"Ananthakrishnan","year":"2017","journal-title":"Inflamm Bowel Dis"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2020.02.032_bib17","first-page":"S68","article-title":"The impact of inflammatory bowel disease in Canada 2018: IBD in seniors","volume":"2","author":"Nguyen","year":"2019","journal-title":"J\u00a0Can Assoc Gastroenterol"},{"key":"10.1053\/j.gastro.2020.02.032_bib18","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1097\/MIB.0000000000001115","article-title":"Inflammatory bowel disease is similar in patients with older onset and younger onset","volume":"23","author":"Kochar","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2020.02.032_bib19","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/MIB.0000000000000747","article-title":"Medication utilization and the impact of continued corticosteroid use on patient-reported outcomes in older patients with inflammatory bowel disease","volume":"22","author":"Geisz","year":"2016","journal-title":"Inflamm Bowel Dis"},{"issue":"9868","key":"10.1053\/j.gastro.2020.02.032_bib20","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","article-title":"Frailty in elderly people","volume":"381","author":"Clegg","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"10.1053\/j.gastro.2020.02.032_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13690-015-0068-x","article-title":"Burden of frailty in the elderly population: perspectives for a public health challenge","volume":"73","author":"Buckinx","year":"2015","journal-title":"Arch Public Health"},{"key":"10.1053\/j.gastro.2020.02.032_bib22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.coi.2014.03.007","article-title":"Inflammation, ageing and chronic disease","volume":"29","author":"Pawelec","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"10.1053\/j.gastro.2020.02.032_bib23","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.clml.2019.09.610","article-title":"Combination of frailty status and comorbidity score improves the stratification of survival in patients with myelodysplastic syndrome owing to good predictive capability for infection-related mortality","volume":"19","author":"Sakatoku","year":"2019","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1053\/j.gastro.2020.02.032_bib24","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/MIB.0b013e31828133fd","article-title":"Improving case definition of Crohn\u2019s disease and ulcerative colitis in electronic medical records using natural language processing: a novel informatics approach","volume":"19","author":"Ananthakrishnan","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2020.02.032_bib25","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.cgh.2014.07.018","article-title":"Colonoscopy is associated with a reduced risk for colon cancer and mortality in patients with inflammatory bowel diseases","volume":"13","author":"Ananthakrishnan","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10132","key":"10.1053\/j.gastro.2020.02.032_bib26","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0140-6736(18)30668-8","article-title":"Development and validation of a Hospital Frailty Risk Score focusing on older people in acute care settings using electronic hospital records: an observational study","volume":"391","author":"Gilbert","year":"2018","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2020.02.032_bib27","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/jamia.2009.001560","article-title":"Mayo clinical Text Analysis and Knowledge Extraction System (cTAKES): architecture, component evaluation and applications","volume":"17","author":"Savova","year":"2010","journal-title":"J\u00a0Am Med Inform Assoc"},{"issue":"Database issue","key":"10.1053\/j.gastro.2020.02.032_bib28","doi-asserted-by":"crossref","first-page":"D267","DOI":"10.1093\/nar\/gkh061","article-title":"The Unified Medical Language System (UMLS): integrating biomedical terminology","volume":"32","author":"Bodenreider","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"10.1053\/j.gastro.2020.02.032_bib29","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/MIB.0000000000000754","article-title":"Comparative effectiveness of infliximab and adalimumab in Crohn\u2019s disease and ulcerative colitis","volume":"22","author":"Ananthakrishnan","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2020.02.032_bib30","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A\u00a0new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J\u00a0Chronic Dis"},{"key":"10.1053\/j.gastro.2020.02.032_bib31","first-page":"389","article-title":"Frailty and cause-specific hospitalization among persons aging with HIV infection and injection drug use","volume":"72","author":"Piggott","year":"2017","journal-title":"J\u00a0Gerontol A Biol Sci Med Sci"},{"key":"10.1053\/j.gastro.2020.02.032_bib32","doi-asserted-by":"crossref","first-page":"899","DOI":"10.3748\/wjg.v23.i5.899","article-title":"Frailty is independently associated with increased hospitalisation days in patients on the liver transplant waitlist","volume":"23","author":"Sinclair","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2020.02.032_bib33","first-page":"346","article-title":"The role of Edmonton frailty scale and ASA grade in the assessment of morbidity and mortality after fracture neck of femur in elderly","volume":"85","author":"Rajeev","year":"2019","journal-title":"Acta Orthop Belg"},{"key":"10.1053\/j.gastro.2020.02.032_bib34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000500086","article-title":"Frailty predicts\u00a0severe postoperative complication after elective hepatic resection","volume":"6","author":"Okabe","year":"2019","journal-title":"Gastrointest Tumors"},{"key":"10.1053\/j.gastro.2020.02.032_bib35","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/s41569-018-0064-2","article-title":"Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty","volume":"15","author":"Ferrucci","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1053\/j.gastro.2020.02.032_bib36","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/ni1033","article-title":"Age-related changes in lymphocyte development and function","volume":"5","author":"Linton","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1053\/j.gastro.2020.02.032_bib37","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1023\/A:1006611518223","article-title":"Thymic involution in aging","volume":"20","author":"Aspinall","year":"2000","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1053\/j.gastro.2020.02.032_bib38","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fimmu.2013.00271","article-title":"Human T cell aging and the impact of persistent viral infections","volume":"4","author":"Fulop","year":"2013","journal-title":"Front Immunol"},{"key":"10.1053\/j.gastro.2020.02.032_bib39","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/ajcn\/51.5.749","article-title":"Impact of nutrition status on morbidity and mortality in a select population of geriatric rehabilitation patients","volume":"51","author":"Sullivan","year":"1990","journal-title":"Am J Clin Nutr"},{"key":"10.1053\/j.gastro.2020.02.032_bib40","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.cgh.2018.12.032","article-title":"Safety of biologic therapy in older patients with immune-mediated diseases: a systematic review and meta-analysis","volume":"17","author":"Borren","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2020.02.032_bib41","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/MIB.0000000000000993","article-title":"Risk of surgery and mortality in elderly-onset inflammatory bowel disease: a population-based cohort study","volume":"23","author":"Nguyen","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2020.02.032_bib42","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/ecco-jcc\/jjw054","article-title":"Systematic review and meta-analysis: phenotype and clinical outcomes of older-onset inflammatory bowel disease","volume":"10","author":"Ananthakrishnan","year":"2016","journal-title":"J\u00a0Crohns Colitis"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508520302432?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508520302432?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T09:45:18Z","timestamp":1762163118000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508520302432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S0016508520302432"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2020.02.032","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pretreatment Frailty Is Independently Associated With Increased Risk of Infections After Immunosuppression in Patients With Inflammatory Bowel Diseases","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2020.02.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the AGA Institute","name":"copyright","label":"Copyright"}]}}